Wilson Disease Drugs Market Segmentation:
Indication Segment Analysis
The global Wilson disease drugs market is segmented and analyzed for demand and supply by indication into hepatic, neurological, ophthalmic, and psychiatric. Out of these types of indications, the neurological segment is estimated to gain the largest market share in the year 2035. Wilson’s disease includes a higher number of neurological indications such as dysarthria (difficulty in speaking), dysphagia (difficulty in swallowing), tremors, poor coordination, spasticity, involuntary movements, muscle rigidity, dystonic posture, and others. Apart from that, the surge in neurological conditions and usage of neurology devices across the globe has also spurred the demand for medical drugs to cure or manage these diseases which are also expected to propel the growth of the segment over the upcoming decades. For instance, based on the statistics released by Pan American Health Organization (PAHO), it was stated that in 2019, nearly 533,172 people died owing to neurological conditions across the globe, out of which, 320,043 were women while 213,129 were men.
Drug Type Segment Analysis
The global Wilson disease drugs market is also segmented and analyzed for demand and supply by drug type into chelating agents, zinc, tetrathiomolybdate, and others. Amongst these segments, the chelating agents’ segment is expected to garner a significant share in the year 2035. Chelating agents include trientine, penicillamine, and dimercaprol which are helpful in reducing the levels of copper in blood and tissues when administered for a prolonged time period. These agents are further helpful in preventing the gathering of copper and injuries from Wilson disease. Chelating agents are developed to flush toxic metals out of the body. Toxic metals are known to cause immune system dysfunction, nervous systems disorders, cancer, birth defects, skin lesions, vascular damage, and many more. A surge in the nervous system disorder and cancer can be observed across the globe which is expected to hike the segment growth over the forecast period. As of 2020, nearly 10 million people lost their lives worldwide.
Our in-depth analysis of the global market includes the following segments:
|
By Indication |
|
|
By Drug Type |
|
|
By End-User |
|
